射血分数保留的心力衰竭的治疗干预措施：当前证据总结
Therapeutic interventions for heart failure with preserved ejection fraction: A summary of current evidence.
作者信息
Asrar ul Haq Muhammad, Wong Chiew, Mutha Vivek, Anavekar Nagesh, Lim Kwang, Barlis Peter, Hare David L
机构信息
Muhammad Asrar ul Haq, Chiew Wong, Vivek Mutha, Nagesh Anavekar, Peter Barlis, Department of Cardiology, The Northern Hospital, Epping, VIC 3076, Australia.
出版信息
World J Cardiol. 2014 Feb 26;6(2):67-76. doi: 10.4330/wjc.v6.i2.67.
Abstract
Heart failure with preserved ejection fraction (HFPEF) is common and represents a major challenge in cardiovascular medicine. Most of the current treatment of HFPEF is based on morbidity benefits and symptom reduction. Various pharmacological interventions available for heart failure with reduced ejection fraction have not been supported by clinical studies for HFPEF. Addressing the specific aetiology and aggressive risk factor modification remain the mainstay in the treatment of HFPEF. We present a brief overview of the currently recommended therapeutic options with available evidence.
摘要
射血分数保留的心力衰竭（HFpEF）很常见，是心血管医学中的一项重大挑战。目前，HFpEF的大多数治疗都是基于降低发病率和减轻症状。各种用于射血分数降低的心力衰竭的药物干预措施尚未得到HFpEF临床研究的支持。针对特定病因和积极改变危险因素仍然是HFpEF治疗的主要方法。我们简要概述了目前推荐的治疗选择及现有证据。
相似文献
1
Therapeutic interventions for heart failure with preserved ejection fraction: A summary of current evidence.射血分数保留的心力衰竭的治疗干预措施：当前证据总结
World J Cardiol. 2014 Feb 26;6(2):67-76. doi: 10.4330/wjc.v6.i2.67.
2
Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball.射血分数保留的心力衰竭与未来药物治疗策略：展望未来
Curr Cardiol Rep. 2017 Aug;19(8):70. doi: 10.1007/s11886-017-0874-6.
3
Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.应变成像技术评估射血分数保留心力衰竭患者的收缩功能障碍。
J Am Coll Cardiol. 2014 Feb 11;63(5):447-56. doi: 10.1016/j.jacc.2013.09.052. Epub 2013 Oct 30.
4
Treatment of hypertension in heart failure with preserved ejection fraction.射血分数保留的心力衰竭患者的高血压治疗
Curr Hypertens Rev. 2014;10(3):142-8. doi: 10.2174/1573402111666141217112216.
5
Animal models of heart failure with preserved ejection fraction.射血分数保留的心力衰竭动物模型。
Neth Heart J. 2016 Apr;24(4):275-86. doi: 10.1007/s12471-016-0815-9.
6
Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.射血分数保留的心力衰竭大鼠中，中枢化学反射激活会加重心脏舒张功能和自主神经功能障碍。
J Physiol. 2017 Apr 15;595(8):2479-2495. doi: 10.1113/JP273558. Epub 2017 Mar 19.
7
Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.心肌细胞功能病因在射血分数保留心力衰竭中有独特表现——一种新的临床前模型。
J Am Heart Assoc. 2018 Jun 1;7(11):e007451. doi: 10.1161/JAHA.117.007451.
8
Treatment of Heart Failure with Preserved Ejection Fraction.射血分数保留型心力衰竭的治疗。
Adv Exp Med Biol. 2018;1067:67-87. doi: 10.1007/5584_2018_149.
9
[Heart failure with preserved ejection fraction (HFpEF)].射血分数保留的心力衰竭（HFpEF）
Ther Umsch. 2018 Sep;75(3):161-169. doi: 10.1024/0040-5930/a000983.
10
Heart Failure with Preserved Ejection Fraction-a Concise Review.射血分数保留的心力衰竭——简要综述。
Curr Cardiol Rep. 2020 Jul 9;22(9):82. doi: 10.1007/s11886-020-01349-3.
引用本文的文献
1
The Role of Myocardial Revascularization in Ischemic Heart Failure in the Era of Modern Optimal Medical Therapy.现代最佳药物治疗时代心肌血运重建在缺血性心力衰竭中的作用
Medicina (Kaunas). 2025 Aug 12;61(8):1451. doi: 10.3390/medicina61081451.
2
A Narrative Review on the Efficacy and Safety of Loop Diuretics in Patients With Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction.关于袢利尿剂在射血分数降低和射血分数保留的心力衰竭患者中的疗效和安全性的叙述性综述
Cureus. 2023 Sep 22;15(9):e45794. doi: 10.7759/cureus.45794. eCollection 2023 Sep.
3
Nuclear localization of a novel calpain-2 mediated junctophilin-2 C-terminal cleavage peptide promotes cardiomyocyte remodeling.新型钙蛋白酶-2 介导的连接蛋白-2 C 端切割肽的核定位促进心肌细胞重构。
Basic Res Cardiol. 2020 Jun 26;115(4):49. doi: 10.1007/s00395-020-0807-1.
4
Effect of Valsartan on Sarcoplasmic Reticulum Ca2+-ATPase Pump of the Left Ventricular Myocardium in Rats with Heart Failure with Preserved Ejection Fraction.缬沙坦对射血分数保留的心力衰竭大鼠左心室心肌肌浆网Ca2+ -ATP酶泵的影响
Biomed Hub. 2016 Jul 30;1(2):1-9. doi: 10.1159/000448132. eCollection 2016 May-Aug.
5
Obesity and metabolic features associated with long-term developing diastolic dysfunction in an initially healthy population-based cohort.在一个最初健康的基于人群的队列中，肥胖和代谢特征与长期发展的舒张功能障碍有关。
Clin Res Cardiol. 2018 Oct;107(10):887-896. doi: 10.1007/s00392-018-1259-6. Epub 2018 Apr 21.
6
Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose.研究方案，随机对照试验：使用泛醇和/或D-核糖减轻射血分数保留的心力衰竭患者的症状负担
BMC Cardiovasc Disord. 2018 Apr 2;18(1):57. doi: 10.1186/s12872-018-0796-2.
7
Alternative Splicing of Titin Restores Diastolic Function in an HFpEF-Like Genetic Murine Model (TtnΔIAjxn).肌联蛋白的可变剪接可恢复类似射血分数保留型心力衰竭遗传小鼠模型（TtnΔIAjxn）的舒张功能。
Circ Res. 2016 Sep 2;119(6):764-72. doi: 10.1161/CIRCRESAHA.116.308904. Epub 2016 Jul 28.
8
Heart Failure with Preserved Ejection Fraction - Concept, Pathophysiology, Diagnosis and Challenges for Treatment.射血分数保留的心力衰竭——概念、病理生理学、诊断及治疗挑战
Open Access Maced J Med Sci. 2015 Sep 15;3(3):521-7. doi: 10.3889/oamjms.2015.087. Epub 2015 Jul 28.
9
Mast Cell Inhibition Attenuates Cardiac Remodeling and Diastolic Dysfunction in Middle-aged, Ovariectomized Fischer 344 × Brown Norway Rats.肥大细胞抑制可减轻中年去卵巢Fischer 344×Brown Norway大鼠的心脏重塑和舒张功能障碍。
J Cardiovasc Pharmacol. 2016 Jul;68(1):49-57. doi: 10.1097/FJC.0000000000000385.
10
Concomitant coronary and renal revascularization improves left ventricular hypertrophy more than coronary stenting alone in patients with ischemic heart and renal disease.对于患有缺血性心脏和肾脏疾病的患者，同期进行冠状动脉和肾脏血运重建比单纯冠状动脉支架置入术更能改善左心室肥厚。
J Zhejiang Univ Sci B. 2016 Jan;17(1):67-75. doi: 10.1631/jzus.B1500071.
本文引用的文献
1
Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.射血分数保留心力衰竭中心脏结构和功能：醛固酮拮抗剂治疗保留心脏功能心力衰竭的超声心动图研究的基线发现。
Circ Heart Fail. 2014 Jan;7(1):104-15. doi: 10.1161/CIRCHEARTFAILURE.113.000887. Epub 2013 Nov 18.
2
Cardiac aging and rejuvenation--a sense of humors?心脏衰老与年轻化——一种幽默的说法？
N Engl J Med. 2013 Aug 8;369(6):575-6. doi: 10.1056/NEJMcibr1306063.
3
Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy.生长分化因子 11 是一种循环因子，可逆转与年龄相关的心肌肥厚。
Cell. 2013 May 9;153(4):828-39. doi: 10.1016/j.cell.2013.04.015.
4
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.磷酸二酯酶-5 抑制剂对射血分数保留心力衰竭患者运动能力和临床状态的影响：一项随机临床试验。
JAMA. 2013 Mar 27;309(12):1268-77. doi: 10.1001/jama.2013.2024.
5
Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.螺内酯对射血分数保留的心力衰竭患者舒张功能和运动能力的影响：Aldo-DHF 随机对照试验。
JAMA. 2013 Feb 27;309(8):781-91. doi: 10.1001/jama.2013.905.
6
Calcium mishandling in diastolic dysfunction: mechanisms and potential therapies.舒张功能障碍中的钙处理异常：机制与潜在治疗方法
Biochim Biophys Acta. 2013 Apr;1833(4):895-900. doi: 10.1016/j.bbamcr.2012.09.007. Epub 2012 Sep 27.
7
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.血管紧张素受体脑啡肽酶抑制剂 LCZ696 治疗射血分数保留的心力衰竭的 II 期双盲随机对照试验。
Lancet. 2012 Oct 20;380(9851):1387-95. doi: 10.1016/S0140-6736(12)61227-6. Epub 2012 Aug 26.
8
New treatment options for late Na current, arrhythmias, and diastolic dysfunction.针对晚钠电流、心律失常和舒张功能障碍的新治疗选择。
Curr Heart Fail Rep. 2012 Sep;9(3):183-91. doi: 10.1007/s11897-012-0099-3.
9
Alagebrium in combination with exercise ameliorates age-associated ventricular and vascular stiffness.阿伐格雷布与运动联合改善与年龄相关的心室和血管僵硬。
Exp Gerontol. 2012 Aug;47(8):565-72. doi: 10.1016/j.exger.2012.04.006. Epub 2012 Apr 28.
10
Heart rate reduction induced by the if current inhibitor ivabradine improves diastolic function and attenuates cardiac tissue hypoxia.伊伐布雷定引起的心率降低可改善舒张功能并减轻心肌组织缺氧。
J Cardiovasc Pharmacol. 2012 Mar;59(3):260-7. doi: 10.1097/FJC.0b013e31823e5e01.
Zotero 插件